Agilent Technologies Inc (A)
Agilent Technologies Inc (A) carries a ŷRobot AI score of 71 out of 100. The model's fair value estimate is $191.76, 9.2% above the last close of $175.61. The chart signal reads S-Sell.
| Metric | A |
|---|---|
| AI score | 71 / 100 |
| Chart signal | S-Sell |
| Fair value estimate | $191.76 |
| Upside to fair value | 9.2% |
| Previous close | $175.61 |
| P/E | 34.59 |
| Price / sales | 6.37 |
| Market cap | $48.38B |
| EPS | 5.06 |
| Revenue growth | -0.0% |
| 1-year price change | 2.2% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about A
Is A overvalued or undervalued right now?
As of Oct 15, 2026, ŷRobot's fair-value model estimates Agilent Technologies Inc (A) at $191.76 against a last close of $175.61, implying 9.2% upside to the model's estimate.
Is A's chart signal bullish or bearish?
The chart-signal model classifies A as Bearish as of Oct 15, 2026, with a signal score of -0.17 on a -1 to 1 scale.
What is A's ŷRobot AI score?
A scores 71 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 15, 2026.
Is A stock expensive on P/E and P/S?
A trades at 34.6 times earnings and 6.4 times sales as of Oct 15, 2026.
What does A's seasonal forecast show?
ŷRobot's seasonal forecast curve for A reads +1.6% at 30 days, +3.8% at 90 days, and +2.2% at one year as of Oct 15, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is A growing?
Agilent Technologies Inc's revenue growth is -0.0% and free-cash-flow growth is +1.5% on the latest reported figures.
A chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.